CIK 0001504776 · Large accelerated filer
Warby Parker Inc.
Sign in to watch- Ticker
- WRBY
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800423634
- Phone
- (646) 847-7215
- Business address
- 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
- Former names
- JAND, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,861,485
- in 5 filings, $7.9M under 10b5-1 plans
Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | Raider Jeffrey Jacob Director | Sale 10b5-1 | −7,500 | $30.00 | $225K | 412,701 |
| 2026-11-09 | Gilboa David Abraham Co-Chief Executive Officer | Conversion 10b5-1 | +75,402 | 115,808 | ||
| 2026-11-09 | Gilboa David Abraham Co-Chief Executive Officer | Sale 10b5-1 | −75,402 | $29.82 | $2.2M | 40,406 |
| 2026-11-09 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −75,402 | 463,789 | ||
| 2026-11-09 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Class B Common Stock 10b5-1 | +75,402 | $3.83 | $289K | 4,651,809 |
| 2026-11-09 | Gilboa David Abraham Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −75,402 | 4,576,407 | ||
| 2026-11-09 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion 10b5-1 | +73,133 | 109,153 | ||
| 2026-11-09 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale 10b5-1 | −73,133 | $30.13 | $2.2M | 36,020 |
| 2026-11-09 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −73,133 | 3,583,465 | ||
| 2026-11-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −310,759 | 0 | ||
| 2026-11-03 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Class B Common Stock | +310,759 | $3.83 | $1.2M | 3,656,598 |
| 2026-10-01 | Raider Jeffrey Jacob Director | Sale 10b5-1 | −15,000 | $27.70 | $416K | 420,201 |
| 2026-10-01 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion 10b5-1 | +95,614 | 136,020 | ||
| 2026-10-01 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale 10b5-1 | −100,000 | $27.69 | $2.8M | 36,020 |
| 2026-10-01 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −95,614 | 3,345,839 | ||
| 2026-09-02 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise | +9,815 | 40,927 | ||
| 2026-09-02 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise | +10,983 | 51,910 | ||
| 2026-09-02 | Gilboa David Abraham Co-Chief Executive Officer | Shares withheld for taxes | −11,504 | $24.19 | $278K | 40,406 |
| 2026-09-02 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −44,640 | 333,144 | ||
| 2026-09-02 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Class B Common Stock | +44,640 | 4,600,044 |
Page 1 of 20 · 390 trades